APELLIS PHARMACEUTICALS
Apellis Pharmaceuticals is an early-stage biotechnology company focused on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease. The company is leveraging courageous science, creativity, and compassion to deliver life-changing medicines. They aim to develop best-in-class and first-in-class therapies for a broad range of debilitating diseases that are driven by uncontrolled or excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. It was founded in 2008 and headquartered in Waltham, Massachusetts, United States.
APELLIS PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2008-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.apellis.com
Total Employee:
101+
Status:
Active
Contact:
502-241-4114
Email Addresses:
[email protected]
Total Funding:
168.53 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Sitelinks Search Box
Similar Organizations
AcelRx Pharmaceuticals
AcelRx Pharmaceuticals focuses on the development and commercialization of therapies for the treatment of pain and other conditions.
Adial Pharmaceuticals
Adial Pharmaceuticals develops prescription medications for addiction and related disorders.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Allena Pharmaceuticals
Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Arvinas
Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Beryllium Discovery
Beryllium Discovery is a specialized drug discovery contract research organization (CRO), provides research services.
BriaCell Therapeutics
BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.
Ceapro
Ceapro is into developing functionally active ingredients derived from oats and renewable plant resources for healthcare and cosmetic needs.
Cerulean Pharma
Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Click Therapeutics
Click Therapeutics delivers safe and effective digital treatments to patients in need.
Conatus Pharmaceuticals
Conatus Pharmaceuticals is focused on the development of human therapeutics to treat liver failures and cancer.
Corvidia
Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Icosavax
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
Innovus Pharmaceuticals
Innovus Pharmaceuticals develops healthcare products for dermatology, autoimmune, respiratory, and sexual dysfunction diseases.
Purple Biotech
Purple Biotech is an innovative biopharmaceutical drug development company.
VYNE Therapeutics
VYNE Therapeutics developing proprietary, innovative and differentiated therapies in dermatology and beyond.
Neurana Pharmaceuticals
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Novita Pharmaceuticals
Novita Pharmaceuticals is a developer of therapeutic drugs for the treatment of cancer.
RenovoRx
RenovoRx is developing innovative solutions for targeted delivery of fluids to selected sites in the peripheral vascular system.
Rigel Pharmaceuticals
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
Silver Creek Pharmaceuticals
Silver Creek Pharmaceuticals is a biotechnology company, develops protein therapeutics to treat cardiovascular diseases.
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Sorriso Pharmaceuticals
Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.
Sunesis Pharmaceuticals
Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
Theragene Pharmaceuticals
Theragene Pharmaceuticals combines innovative science and efficiency to develop life-saving therapies for many debilitating diseases.
Vigeo Therapeutics
Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.
Zavante Therapeutics
Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2014-11-20 | Potentia Pharmaceuticals | Potentia Pharmaceuticals acquired by Apellis Pharmaceuticals | N/A |
Investors List
Solasta Ventures
Solasta Ventures investment in Post-IPO Equity - Apellis Pharmaceuticals
venBio Partners
venBio Partners investment in Series E - Apellis Pharmaceuticals
Epidarex Capital
Epidarex Capital investment in Series E - Apellis Pharmaceuticals
Morningside Venture Investments
Morningside Venture Investments investment in Series E - Apellis Pharmaceuticals
Clough Capital Partners
Clough Capital Partners investment in Series E - Apellis Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series E - Apellis Pharmaceuticals
Sectoral Asset Management
Sectoral Asset Management investment in Series E - Apellis Pharmaceuticals
F-Prime Capital
F-Prime Capital investment in Series E - Apellis Pharmaceuticals
Vivo Capital
Vivo Capital investment in Series E - Apellis Pharmaceuticals
Cormorant Asset Management
Cormorant Asset Management investment in Series E - Apellis Pharmaceuticals
Official Site Inspections
http://www.apellis.com Semrush global rank: 1.3 M Semrush visits lastest month: 22.6 K
- Host name: ec2-3-141-146-16.us-east-2.compute.amazonaws.com
- IP address: 3.141.146.16
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215